Skip to content
IPHAInnate Pharma SA

IPHA holders

Who holds Innate Pharma SA, from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
12
Shares held
209.6K
Value held
$341.7K
Opened
4
Closed
2

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Lion Point Capital, LP81.2K±0%$132.3K0.8%Nov 16, 2026
Morgan Stanley43.5K±0%$70.9K0%Nov 13, 2026
Citadel Advisors LLC27.6K+121.8%$45K0%Nov 16, 2026
SmartHarvest Portfolios, LLC20.9K−12.1%$34K0.1%Oct 26, 2026
BNP Paribas Financial Markets11.3KNew$18.4K0%Nov 12, 2026
Millennium Management LLC10.2KNew$16.7K0%Nov 16, 2026
Tocqueville Asset Management L.P.10KNew$16.3K0.1%Nov 13, 2026
Rhumbline Advisers4.7K±0%$7.7K0%Nov 10, 2026
UBS Group AG146−89.3%$2380%Nov 10, 2026
Caitong International Asset Management Co., Ltd74New$1210%Oct 29, 2026
Farther Finance Advisors, LLC10−52.4%$160%Oct 8, 2026
GAMMA Investing LLC9±0%$150%Oct 8, 2026